AIBS has provided testimony to the House Appropriations Committee regarding fiscal year (FY) 2026 funding for the National Institutes of Health (NIH).
AIBS urged Congress to provide NIH with a base budget of at least $51.3 billion in FY 2026, arguing that this level of funding is needed to “grow and sustain the U.S. bioeconomy and enable NIH to accelerate work on important initiatives at the frontiers of science and medicine.” The testimony emphasized that the requested funding “will enable the agency to support research in a number of important priority areas, including fighting cancer, advancing nutrition science, improving neurological health, tackling the opioid epidemic, eradicating HIV, expanding mental health research, addressing health disparities and inequities, and investigating the human health impacts of climate change.”
AIBS further requested that any additional funding to support the Advanced Research Projects Agency for Health (ARPA-H) should supplement, not supplant, the $51.3 billion recommendation for NIH.
Stay current on the latest science policy news. Subscribe to our bi-weekly AIBS Public Policy Report.